Advisory Board

The non-executive scientific advisory board, consisting of four world-renowned external experts in cancer, nuclear receptors and organic chemsitry, will monitor and evaluate the performance of the network, provide strategic advice regarding research and training activities, and will offer independant advice and guidance to the DCs.

The advisory board will attend the annual meetings and give targeted feedback and advice through online meetings with individual DCs. The advisory board will review the progress of each DC annually, will oversee the quality and quantity of supervision and report to the supervisory board.

Prof. Suzanne Turner

University of Cambridge, UK

Suzanne Turner is a Professor of childhood cancer biology at the University of Cambridge where she leads a research group with a focus on paediatric lymphoma. Research in the lab aims to understand the origins and mechanisms of childhood lymphomagenesis and to apply this to developing kinder therapeutic approaches. Most recently, the lab has been conducting research to understand mechanisms of resistance to targeted therapeutic agents using genome-wide CRISPR screens and patient derived xenografts.

Prof. Antonio Mouriño Mosquera

University of Santiago di Compostela, Spain

Professor Antonio Mouriño Mosquera is a world leading expert on vitamin D chemistry.

Prof. Cesar Cobaleda

Centro de Biología Molecular Severo Ochoa, Madrid, Spain

César Cobaleda is Scientific Researcher of the Spanish Research Council (CSIC) at the Centro de Biología Molecular Severo Ochoa (CBMSO, Madrid). PhD Degree in Biology from the Univ. of Salamanca (1997). Postdocs in i) the Cancer Research Center in Salamanca, studying cancer stem cells, and ii) in the group of M. Busslinger at the IMP (Vienna), working in B-cell lineage specification. Tenure at CSIC in 2009. Cobaleda has been investigating normal and aberrant hematopoiesis for more than 27 years, studying both the normal physiological processes of blood cell differentiation and their deregulation in pathological conditions (cancer and developmental syndromes). His lab uses the mouse as an in vivo experimental model (transgenics, knock-outs, knock-ins, constitutive and conditional), to gain insight into the transcriptional and epigenetic mechanisms that regulate the initiation and maintenance of cell identity, and how these mechanisms are deregulated in tumorigenesis and genetic syndromes (v.g. immunodeficiencies).

Prof. Jyotsna Batra

Queensland University of Technology, Australia

Professor Batra is a specialist in genetics, big data analysis, and biological data integration.